NARAZACICLIB

SynDRA canonical compound SYN0037822 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	CCNT1 \| CDK4 \| CDK6 \| CDK9 \| FGFR1 \| FGFR2 \| FLT3 \| FLT4 \| FYN \| LCK \| LYN \| NUAK1 \| PDGFRB \| RET
Mechanism of action	CDK inhibitor

All known targets

CDK4
CDK6
NUAK1
CCNT1
CDK9
FGFR1
FGFR2
FLT3
FLT4
FYN
LCK
LYN

Mechanisms of action (all sources)

CDK4/6 inhibitor
NUAK1 INHIBITOR
cyclin-dependent kinase inhibitor

Cross-references

PubChem CID: 56649281
ChEMBL: CHEMBL3115681
DrugBank: DB19038
PDB: X4H

Synonyms

Look up NARAZACICLIB in the interactive SynDRA portal →